The value of Real World Data (RWD) increases in areas where the development of new treatment options has been slow, primarily due to insufficient medical field experience and limited information beyond randomized controlled trials (RCT).

Atopic dermatitis is one of the fields that has seen a shortage of new drugs in the past. However, in recent years, there have been notable shifts in prescription patterns, with the inclusion of JAK inhibitors and interleukin inhibitors.

Amidst ongoing developments, Korean researchers have unveiled RWD research findings related to the JAK inhibitor 'Rinvoq (upadacitinib)' in Korean patients. The study, led by Professor Ahn Ji Young from the Depar